Gemcitabine, paclitaxel, and radiation for locally advanced pancreatic cancer: a Phase I trial (Q44105601)

29 November 2017

title

Gemcitabine, paclitaxel, and radiation for locally advanced pancreatic cancer: a Phase I trial (English)

1 reference

29 November 2017

main subject

phase I clinical trial

0 references

1 reference

1 reference

Howard Safran

1 reference

29 November 2017

Thomas Dipetrillo

1 reference

29 November 2017

David Iannitti

1 reference

29 November 2017

Daniel Quirk

1 reference

29 November 2017

Paul Akerman

1 reference

29 November 2017

Dennis Cruff

1 reference

29 November 2017

William Cioffi

1 reference

29 November 2017

Samir Shah

1 reference

29 November 2017

Nadia Ramdin

1 reference

29 November 2017

Tyvin Rich

1 reference

29 November 2017

language of work or name

English

0 references

publication date

1 September 2002

1 reference

International Journal of Radiation Oncology Biology Physics

29 November 2017

published in

1 reference

29 November 2017

1 reference

29 November 2017

1 reference

29 November 2017

page(s)

137-141

1 reference

29 November 2017

cites work

Cancer statistics, 2000.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902902-4

7 January 2021

Preoperative combined modality therapy for pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902902-4

7 January 2021

Current management of pancreatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902902-4

7 January 2021

Investigation of taxol as a potential radiation sensitizer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902902-4

7 January 2021

Clinical research in pancreatic cancer: the Radiation Therapy Oncology Group trials

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902902-4

7 January 2021

Phase I trial of twice-weekly gemcitabine and concurrent radiation in patients with advanced pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902902-4

7 January 2021

In vitro studies of Taxol as a radiation sensitizer in human tumor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902902-4

7 January 2021

Cytotoxicity and cell-cycle effects of paclitaxel when used as a single agent and in combination with ionizing radiation

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902902-4

7 January 2021

Effect of radiation and paclitaxel of p53 expression in murine tumors sensitive or resistant to apoptosis induction

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902902-4

7 January 2021

Enhanced radioresponse of paclitaxel-sensitive and -resistant tumours in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902902-4

7 January 2021

p53 mutations do not predict response to paclitaxel/radiation for nonsmall cell lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902902-4

7 January 2021

Paclitaxel and concurrent radiation for locally advanced pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902902-4

7 January 2021

Paclitaxel and concurrent radiation for locally advanced pancreatic and gastric cancer: a phase I study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902902-4

7 January 2021

High-dose preoperative external beam and intraoperative irradiation for locally advanced pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902902-4

7 January 2021

Residual, recurrent, or unresectable gastrointestinal cancer. Role of radiation in single or combined modality treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902902-4

7 January 2021

Combined intraoperative radiation and perioperative chemotherapy for unresectable cancers of the pancreas

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902902-4

7 January 2021

Phase I trial of radiation dose escalation with concurrent weekly full-dose gemcitabine in patients with advanced pancreatic cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902902-4

7 January 2021

Fatal pulmonary toxicity resulting from treatment with gemcitabine

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902902-4

7 January 2021

Noncardiogenic pulmonary edema: an unusual and serious complication of anticancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902902-4

7 January 2021

10.1016/S0360-3016(02)02902-4

Identifiers

DOI

1 reference

29 November 2017

1 reference